We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+29.29%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$9.47B
AUM Growth
+$451M
Cap. Flow
+$1.13B
Cap. Flow %
11.96%
Top 10 Hldgs %
21.59%
Holding
903
New
107
Increased
255
Reduced
393
Closed
103

Top Buys

Rank Stock Value
1
BPMC
Blueprint Medicines
BPMC
+$51.9M
2
MRK icon
Merck
MRK
+$50.9M
3
DHR icon
Danaher
DHR
+$45.3M
4
TMO icon
Thermo Fisher Scientific
TMO
+$37.8M
5
JD icon
JD.com
JD
+$37.7M

Top Sells

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$103M
2
BABA icon
Alibaba
BABA
+$98.6M
3
CRM icon
Salesforce
CRM
+$62.5M
4
BMY icon
Bristol-Myers Squibb
BMY
+$59.4M
5
VRTX icon
Vertex Pharmaceuticals
VRTX
+$48.6M

Sector Composition

Rank Sector Weight
1 Healthcare 34.61%
2 Technology 20.94%
3 Consumer Discretionary 8.9%
4 Financials 8.59%
5 Communication Services 7.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RETA
101
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$24.4M 0.26%
156,584
+41,184
+36% +$6.26M
LOW icon
102
Lowe's Companies
LOW
$119B
$24M 0.25%
177,923
-9,853
-5% -$1.13M
TIF
103
DELISTED
Tiffany & Co.
TIF
$23.6M 0.25%
193,534
+53,234
+38% +$6.67M
AXP icon
104
American Express
AXP
$228B
$23.2M 0.24%
243,219
-168,460
-41% -$15.5M
PLD icon
105
Prologis
PLD
$136B
$22.8M 0.24%
243,909
+80,821
+50% +$7.21M
ANET icon
106
Arista Networks
ANET
$214B
$22.5M 0.24%
1,712,832
+934,064
+120% +$12.6M
BBY icon
107
Best Buy
BBY
$18.7B
$22.4M 0.24%
256,828
+126,827
+98% +$9.62M
VRNS icon
108
Varonis Systems
VRNS
$5.35B
$21.9M 0.23%
740,997
+207,021
+39% +$5.18M
PTC icon
109
PTC
PTC
$14.4B
$21.8M 0.23%
280,245
+13,958
+5% +$989K
OLED icon
110
Universal Display
OLED
$3.78B
$21.8M 0.23%
145,516
+40,212
+38% +$5.9M
ISRG icon
111
Intuitive Surgical
ISRG
$128B
$21.7M 0.23%
114,162
-1,236
-1% -$222K
KOD icon
112
Kodiak Sciences
KOD
$2.66B
$21.6M 0.23%
398,507
+384,160
+2,678% +$21.7M
GTHX
113
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$21.1M 0.22%
870,423
+510,014
+142% +$8.43M
IOVA icon
114
Iovance Biotherapeutics
IOVA
$2.22B
$20.8M 0.22%
757,656
+584,152
+337% +$19.2M
SCCO icon
115
Southern Copper
SCCO
$139B
$20.4M 0.22%
554,027
+18,446
+3% +$584K
EL icon
116
Estee Lauder
EL
$29.6B
$20.4M 0.22%
108,183
+5,909
+6% +$1.06M
BRK.B icon
117
Berkshire Hathaway Class B
BRK.B
$1.07T
$20.3M 0.21%
113,571
-57,900
-34% -$10.6M
EQIX icon
118
Equinix
EQIX
$104B
$20M 0.21%
28,546
+12,619
+79% +$8.54M
BAC icon
119
Bank of America
BAC
$435B
$20M 0.21%
843,268
+321,619
+62% +$7.6M
NTES icon
120
NetEase
NTES
$79.7B
$20M 0.21%
232,900
-31,725
-12% -$2.39M
BZUN
121
Baozun
BZUN
$165M
$19.9M 0.21%
518,000
+404,000
+354% +$12.7M
CDNS icon
122
Cadence Design Systems
CDNS
$94.1B
$19.9M 0.21%
207,354
+76,182
+58% +$6.38M
ZTO icon
123
ZTO Express
ZTO
$18.2B
$19.6M 0.21%
+534,799
New +$17.1M
SBUX icon
124
Starbucks
SBUX
$119B
$19.6M 0.21%
265,723
-117,338
-31% -$8.82M
ECL icon
125
Ecolab
ECL
$76.4B
$19.3M 0.2%
97,134
+40,753
+72% +$7.89M
3 4
5
6 7

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q2 2020 Portfolio in Review

As of Q2 2020, Candriam SCA held 903 positions worth $9.47B, up 5% from $9.02B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Candriam SCA deployed $1.13B of net new capital in Q2 2020, opening 107 new positions and adding to 255 existing holdings. Its largest new stake was JD.com: 744,410 shares worth $44.8M.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 31% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Regeneron Pharmaceuticals, an estimated $103M trimmed.

  • Candriam SCA's largest Q2 2020 buy was JD.com: 744,410 shares worth $44.8M.
  • Candriam SCA added most to Blueprint Medicines in Q2 2020, an estimated $51.9M increase.
  • Candriam SCA's biggest Q2 2020 reduction was Regeneron Pharmaceuticals, cutting an estimated $103M.
  • Candriam SCA fully exited Salesforce in Q2 2020, selling an estimated $62.5M.
  • Candriam SCA's ten largest holdings make up 22% of its $9.47B portfolio in Q2 2020.
  • Candriam SCA opened 107 new positions and closed 103 in Q2 2020.
  • Candriam SCA's portfolio value rose 5% quarter-over-quarter to $9.47B.

Based on Candriam SCA's 13F filing for Q2 2020, filed 23 Jul 2020.